A Study of Obinutuzumab to Evaluate Safety and Tolerability in Hypersensitized Adult Participants With End Stage Renal Disease Awaiting Transplantation
Clinical trial NCT02586051 · COMPLETED
Trial details
- NCT number
- NCT02586051
- Sponsor
- Hoffmann-La Roche
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-19
- Primary completion
- 2018-11-26
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.